EN
Human IFN-lambda-1 / IL-29 recombinant Protein
Product Overview, Sizes and Prices |
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Protein Synonyms: Interleukin-29, IL-29, IFN-Lambda 1, IFN-Lambda 1, Cytokine ZCYTO21, IL29, IFNL1, ZCYTO21. Source: E. coli Biological activity: See below Purity: ≥ 90 % (SDS-PAGE, RP-HPLC) Physical state: Lyophilized Manufacturer: |
|
||||||||||||||||||||
Active Bioscience
Product Details
Synonyms
Interleukin-29, IL-29, IFN-Lambda 1, IFN-Lambda 1, Cytokine ZCYTO21, IL29, IFNL1, ZCYTO21.
Description of Human IFN-lambda-1 / IL-29
Recombinant Human IFN-lambda-1/IL-29 derived from E. coli is a 20 kDa single, non-glycosylated, protein consist-ing of 181 amino acids. It is distantly related to type I Interferons (IFNs) and the IL-10 family. Expression of Human IFN-lambda-1 (Interleukin 29) is induced by viral infection which interacts with a heterodimeric class II cytokine re-ceptor that consists of interleukin 10 receptor-beta (IL10rb) and interleukin 28 receptor-alpha. Human IFN-lambda-1 (Interleukin 29) exhibits common features with type I IFNs such as antiviral activity, antiproliferative activity and in vivo antitumor activity. Even so it acts similarly to IFNs, it is generally less effective and has activity only in a more limited range of cell lines. The genes for IFN-lambda-1, IFN-lambda-2 and IFN-lambda-3 are closely positioned on human chromosome 19. Human IFN-lambda-1 (Interleukin 29) induces ELR(-) CXC-chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner. It can generate tolerogenic Dendritic Cells (DCs), an activity that could thwart IFN-beta functions. If Human IFN-lambda-1 (Interleukin 29) is produced in response to viral infection, it activates both monocytes and macrophages producing a restricted panel of cytokines and therefore is an important factor in activating innate immune responses at the site of viral infection. IFN-Lambda 1 antiviral and antiproliferative activity requires IFN-Lambda 2 receptor tyrosine residues.
Biological Activity
An ED50 of 0.2-0.5 ng/ml was found by testing its ability to activate STAT phosphorylation in an ISRE Luciferase Reporter Assay using human colon carcinoma COLO205 cells.
Reconstitution
We recommend a quick spin followed by reconstitution in sterile water to a concentration of at least 100 µg/ml, which can then be further diluted to other aqueous solutions. Do not vortex.
Stability
Lyophilized IFN-Lambda-1 is stable at room temperature for up to 3 weeks, but best stored below -18°C. Reconstitut-ed IFN-Lambda-1 can be stored at 4°C for 2-7 days and for future use below -18°C. For long term storage it is rec-ommended to add a carrier protein (0.1% HSA, order number: 2835.955.xyz or 2835.958.xyz, or BSA, order number: 2835.919.xyz). Please avoid repeated freeze-thaw cycles.
Amino Acid Sequence
GPVPTSKPTT TGKGCHIGRF KSLSPQELAS FKKARDALEE SLKLKNWSCS SPVFPGNWDL RLLQVRERPV ALEAELALTL KVLEAAAGPA LEDVLDQPLH TLHHILSQLQ ACIQPQPTAG PRPRGRLHHW LHRLQEAPKK ESAGCLEASV TFNLFRLLTR DLKYVADGNL CLRTSTHPES T
Shipped at room temperature
To buy Human IFN-lambda-1 / IL-29 please click on the Shopping List Symbol right from the indicated price. This will add the product to your Shopping List. You can then click on the button »Shopping List & Order Form« or the Shopping List Symbol in the top navigation to ask for a quote. We will send you your quote as soon as possible. Our offer will include institutional discounts where applicable. Human IFN-lambda-1 / IL-29 is an alternative for the no longer available Promokine IFN-lambda-1 (IL-29), human, recombinant (E. coli) (C-60730).
All prices are net prices (excluding VAT). Final prices in our quote will contain VAT plus shipping costs if applicable. For further information please go to our Shipping page.
Errors, changes and availability excepted.
Payment Methods
Paying by bank transfer
